{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T06:48:17Z","timestamp":1763534897521},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1007\/s11926-005-0038-3","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T14:18:04Z","timestamp":1180793884000},"page":"281-287","source":"Crossref","is-referenced-by-count":11,"title":["Infection-related vasculitis"],"prefix":"10.1007","volume":"7","author":[{"given":"Omondi","family":"Oyoo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis R.","family":"Espinoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"38_CR1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11926-003-0041-5","volume":"5","author":"N Mohan","year":"2003","unstructured":"Mohan N, Kerr G: Infectious etiology of vasculitis: diagnosis and management. Curr Rheumatol Rep 2003, 5:136\u2013141.","journal-title":"Curr Rheumatol Rep"},{"key":"38_CR2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3949\/ccjm.69.Suppl_2.SII15","volume":"69","author":"SJ Naides","year":"2002","unstructured":"Naides SJ: Known causes of vasculitis in man. Cleve Clin J Med 2002, 69(Suppl):15\u201323.","journal-title":"Cleve Clin J Med"},{"key":"38_CR3","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1128\/JVI.71.6.4809-4814.1997","volume":"71","author":"BT Tinkle","year":"1997","unstructured":"Tinkle BT, Ngo L, Luciw PA, et al.: Human immunodeficiency virus associated vasculopathy in transgenic mice. J Virol 1997, 71:4809\u20134814.","journal-title":"J Virol"},{"key":"38_CR4","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/0090-1229(81)90225-7","volume":"21","author":"R Inman","year":"1981","unstructured":"Inman R, McDougal JS, Redecha PB, et al.: Isolation and characterization of immune complexes in patients with hepatitis B systemic vasculitis. Clin Immunol Immunopathol 1981, 21:364\u2013374.","journal-title":"Clin Immunol Immunopathol"},{"key":"38_CR5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1055\/s-2008-1063929","volume":"1","author":"JL Dienstag","year":"1981","unstructured":"Dienstag JL: Hepatitis B as an immune complex disease. Semin Liver Dis 1981, 1:45\u201347.","journal-title":"Semin Liver Dis"},{"key":"38_CR6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1006\/jaut.2000.0502","volume":"16","author":"C Trepo","year":"2001","unstructured":"Trepo C, Guillevin L: Polyarteritis nodosa and extrahepatic manifestations of HBV infection: the case against autoimmune intervention in pathogenesis. J Autoimmun 2001, 16:269\u2013274.","journal-title":"J Autoimmun"},{"key":"38_CR7","first-page":"1575","volume":"78","author":"C Trepo","year":"1970","unstructured":"Trepo C, Thivole J: Antigen Australia hepatite a virus et periarterite noueuse. Presse Med 1970, 78:1575.","journal-title":"Presse Med"},{"key":"38_CR8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/art.20077","volume":"51","author":"A Mahr","year":"2004","unstructured":"Mahr A, Guillevin L, Poissonnet M, Aym\u00e9 S: Prevalence of polyarteritis nodosa, microscopic polyangiitis, Wegener\u2019s granulomatosis and Churg Strauss syndrome in a French urban population in 2000: a capture-recapture estimate. Arthritis Rheum 2004, 51:92\u201399.","journal-title":"Arthritis Rheum"},{"key":"38_CR9","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00005792-199509000-00002","volume":"74","author":"L Guillevin","year":"1995","unstructured":"Guillevin L, Lhote F, Cohen P, et al.: Polyarteritis nodosa related to hepatitis B virus: a prospective study with longterm observation of 41 patients. Medicine 1995, 74:238\u2013253.","journal-title":"Medicine"},{"key":"38_CR10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00005792-199601000-00003","volume":"75","author":"L Guillevin","year":"1996","unstructured":"Guillevin L, Lhote F, Gayraud M, et al.: Prognostic factors in polyarteritis nodosa and Churg-Strauss Syndrome: a prospective study in 342 patients. Medicine 1996, 75:17\u201328.","journal-title":"Medicine"},{"key":"38_CR11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11926-002-0025-x","volume":"4","author":"L Guillevin","year":"2002","unstructured":"Guillevin L, Cohen P: Management of virus induced systemic vasculitides. Curr Rheumatol Rep 2002, 4:60\u201366.","journal-title":"Curr Rheumatol Rep"},{"key":"38_CR12","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/art.20401","volume":"51","author":"L Guillevin","year":"2004","unstructured":"Guillevin L, Mahar A, Cohen P, et al.: Short term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus related polyarteritis nodosa. Arthritis Rheum 2004, 51:482\u2013487. Pilot study assessing efficacy and safety of lamivudine combined with plasma exchanges after short term steroids for HBV related PAN.","journal-title":"Arthritis Rheum"},{"key":"38_CR13","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJM199910213411702","volume":"341","author":"JL Dienstag","year":"1999","unstructured":"Dienstag JL, Schiff ER, Wright TL, et al.: Lamivudine as initial treatment for chronic hepatitis B. N Engl J Med 1999, 341:1256\u20131263.","journal-title":"N Engl J Med"},{"key":"38_CR14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1182\/blood.V100.2.391","volume":"100","author":"O Shibolet","year":"2002","unstructured":"Shibolet O, Ilan Y, Gillis S, et al.: Lamivudine therapy for prevention of immunosuppressive induced hepatitis B virus reactivation in hepatitis B surface antigen carriers. Blood 2002, 100:391\u2013396.","journal-title":"Blood"},{"key":"38_CR15","first-page":"81","volume":"18","author":"F DeKeyser","year":"2000","unstructured":"DeKeyser F, Naeyaert JM, Hindryckx P, et al.: Immune mediated pathology following hepatitis B vaccination. Two cases of polyarteritis nodosa and one case of pityriasis rosea-like drug eruption. Clin Exp Rheumatol 2000, 18:81\u201385.","journal-title":"Clin Exp Rheumatol"},{"key":"38_CR16","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0248-8663(00)00307-6","volume":"22","author":"D Saadoun","year":"2001","unstructured":"Saadoun D, Cacoub P, Mahoux D, et al.: Postvaccine vasculitis: a report of three cases. Rev Med Interne 2001, 22:172\u2013176.","journal-title":"Rev Med Interne"},{"key":"38_CR17","first-page":"2181","volume":"31","author":"EM Begier","year":"2004","unstructured":"Begier EM, Langford CA, Sneller MC, et al.: Polyarteritis nodosa reports to the vaccine adverse event reporting system (VAERS): implications for assessment of suspected vaccineprovoked vasculitis. J Rheumatol 2004, 31:2181\u20132188. Very good analysis of the potential link between vaccines and vasculitis.","journal-title":"J Rheumatol"},{"key":"38_CR18","doi-asserted-by":"crossref","first-page":"296","DOI":"10.7326\/0003-4819-132-4-200002150-00008","volume":"132","author":"TJ Liang","year":"2000","unstructured":"Liang TJ, Rehermann B, Seeft LB, Hoofnagle JH: Pathogenesis, natural history, treatment and prevention of Hepatitis C. Ann Intern Med 2000, 132:296\u2013305.","journal-title":"Ann Intern Med"},{"key":"38_CR19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","volume":"345","author":"GM Laver","year":"2001","unstructured":"Laver GM, Walker BD: Hepatitis C virus infection. N Engl J Med 2001, 345:41\u201352.","journal-title":"N Engl J Med"},{"key":"38_CR20","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D","volume":"42","author":"P Cacoub","year":"1999","unstructured":"Cacoub P, Poynard T, Ghillani P, et al.: Extrahepatic manifestations of chronic hepatitis C. Arthritis Rheum 1999, 42:2204\u20132212.","journal-title":"Arthritis Rheum"},{"key":"38_CR21","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/0016-5085(94)90022-1","volume":"106","author":"F Lunel","year":"1994","unstructured":"Lunel F, Musset L, Cacoub P, et al.: Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 1994, 106:1291\u20131300.","journal-title":"Gastroenterology"},{"key":"38_CR22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00005792-200001000-00005","volume":"79","author":"P Cacoub","year":"2000","unstructured":"Cacoub P, Renou C, Rosentahl E, et al.: Extra hepatic manifestations associated with hepatitis C virus infection: a prospective multicenter study of 321 patients. Medicine 2000, 79:47\u201356.","journal-title":"Medicine"},{"key":"38_CR23","first-page":"2199","volume":"31","author":"D Sene","year":"2004","unstructured":"Sene D, Ghillani-Dalbin P, Thibault V, et al.: Long-term course of mixed cryoglobulinemia in patients infected with hepatitis C virus. J Rheumatol 2004, 31:2199\u20132206. Long term follow-up of HCV mixed cryoglobulinemia to define its natural history.","journal-title":"J Rheumatol"},{"key":"38_CR24","first-page":"484","volume":"32","author":"M Casato","year":"2005","unstructured":"Casato M, Saadoun D, Marchetti A, et al.: Central nervous system involvement in hepatitis C virus cryoglobulinemia vasculitis: a multicenter case-control study using magnetic resonance imaging and neuropsychological tests. J Rheumatol 2005, 32:484\u2013488.","journal-title":"J Rheumatol"},{"key":"38_CR25","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/ard.60.4.385","volume":"60","author":"P Lamprecht","year":"2001","unstructured":"Lamprecht P, Moosig F, Gause A, et al.: Immunological and clinical followup of hepatitis C virus associated cryoglobulinemic vasculitis. Ann Rheum Dis 2001, 60:385\u2013390.","journal-title":"Ann Rheum Dis"},{"key":"38_CR26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/jhep.2001.26371","volume":"34","author":"KL Lindsay","year":"2001","unstructured":"Lindsay KL, Trepo C, Heitges T, et al.: A randomized, double blind trial comparing pegylated interferon alpha 2b to interferon alpha 2b as initial treatment of chronic hepatitis C. Hepatology 2001, 34:395\u2013403.","journal-title":"Hepatology"},{"key":"38_CR27","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","volume":"58","author":"MP Manns","year":"2001","unstructured":"Manns MP, McHutchison JG, Gordon SC, et al.: Peg-interferon alpha 2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C; a randomized trial. Lancet 2001, 58:958\u2013865.","journal-title":"Lancet"},{"key":"38_CR28","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/art.10107","volume":"46","author":"D Vassilopoulus","year":"2002","unstructured":"Vassilopoulus D, Calabrese LH: Hepatitis C virus infection and vasculitis: implications of antiviral and immunosuppressive therapies. Arthritis Rheum 2002, 46:585\u2013597.","journal-title":"Arthritis Rheum"},{"key":"38_CR29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00002281-200205000-00006","volume":"13","author":"DA Rossa","year":"2002","unstructured":"Rossa DA, Tavoni A, Baldini C, Bombardieri S: Treatment of chronic hepatitis C infection with cryoglobulinemia. Curr Opin Rheumatol 2002, 13:231\u2013237.","journal-title":"Curr Opin Rheumatol"},{"key":"38_CR30","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11926-002-0025-x","volume":"4","author":"L Guillevin","year":"2002","unstructured":"Guillevin L, Cohen P: Management of virus-induced systemic vasculitides. Curr Rheumatol Rep 2002, 4:60\u201366.","journal-title":"Curr Rheumatol Rep"},{"key":"38_CR31","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1002\/art.10699","volume":"46","author":"P Cacoub","year":"2002","unstructured":"Cacoub P, Lidove O, Maisonobe T, et al.: Interferon-_ and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 2002, 46:3317\u20133326.","journal-title":"Arthritis Rheum"},{"key":"38_CR32","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.20958","volume":"52","author":"P Cacoub","year":"2005","unstructured":"Cacoub P, Saadoun D, Limal N, et al.: PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 2005, 52:911\u2013915.","journal-title":"Arthritis Rheum"},{"key":"38_CR33","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/rheumatology\/keh080","volume":"43","author":"M-O Chandesris","year":"2004","unstructured":"Chandesris M-O, Gayet S, Schleinitz N, et al.: Infliximab in the treatment of refractory vasculitis secondary to hepatitis C-associated mixed cryoglobulinemia. Rheumatology 2004, 43:532\u2013533.","journal-title":"Rheumatology"},{"key":"38_CR34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ndt\/gfh564","volume":"20","author":"M Koukoulaki","year":"2005","unstructured":"Koukoulaki M, Abeygunasekara SC, Smith KGC, Jayne DRW: Remission of refractory hepatitis C-negative cryoglobulinemic vasculitis after rituximab and infliximab. Nephrol Dial Transplant 2005, 20:213\u2013216.","journal-title":"Nephrol Dial Transplant"},{"key":"38_CR35","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/art.1780360818","volume":"36","author":"R Gherardi","year":"1993","unstructured":"Gherardi R, Belec L, Mhiri C, et al.: The spectrum of vasculitis in human immunodeficiency virus infected patients. Arthritis Rheum 1993, 36:1164\u20131174.","journal-title":"Arthritis Rheum"},{"key":"38_CR36","first-page":"385","volume":"10","author":"BF Mandel","year":"1998","unstructured":"Mandel BF, Calabresse L: Infectious and systemic vasculitis. Curr Opin Rheumatol 1998, 10:385\u2013416.","journal-title":"Curr Opin Rheumatol"},{"key":"38_CR37","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/jcp.54.4.275","volume":"54","author":"R Chetty","year":"2001","unstructured":"Chetty R: Vasculitis associated with HIV infection. J Clin Pathol 2001, 54:275\u2013278.","journal-title":"J Clin Pathol"},{"key":"38_CR38","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1161\/01.CIR.0000031704.78200.59","volume":"106","author":"G Barbaro","year":"2002","unstructured":"Barbaro G: Cardiovascular manifestations of HIV infection. Circulation 2002, 106:1426\u20131430. Recent review exploring the issue of HAART-related vascular complication.","journal-title":"Circulation"},{"key":"38_CR39","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/heart.89.7.793","volume":"89","author":"BD Prendergast","year":"2003","unstructured":"Prendergast BD: HIV and cardiovascular medicine. Heart 2003, 89:793\u2013800. Recent review exploring the issue of HAART-related vascular Complication.","journal-title":"Heart"},{"key":"38_CR40","first-page":"685","volume":"321","author":"R Gherardi","year":"1989","unstructured":"Gherardi R, Lebargy F, Gaulard P, et al.: Necrotizing vasculitis and HIV replication in peripheral nerves. N Engl J Med 1989, 321:685\u2013686.","journal-title":"N Engl J Med"},{"key":"38_CR41","first-page":"310","volume":"48","author":"DS Sachdev","year":"2002","unstructured":"Sachdev DS, Kharkar VD, Mahajan SA, Gupte PD: Erythema elevatum diutinum. J Postgrad Med 2002, 48:310\u2013311.","journal-title":"J Postgrad Med"},{"issue":"Suppl 1","key":"38_CR42","first-page":"S59","volume":"34","author":"JK Rockstroh","year":"2003","unstructured":"Rockstroh JK: Management of hepatitis B and C in HIV coinfected patients. J AIDS 2003, 34(Suppl 1):S59\u201365.","journal-title":"J AIDS"},{"key":"38_CR43","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1097\/00002030-200311070-00002","volume":"17","author":"N Brau","year":"2003","unstructured":"Brau N: Update on chronic hepatitis C in HIV\/HCV coinfected patients: viral interactions and therapy. AIDS 2003, 17:2279\u20132290.","journal-title":"AIDS"},{"key":"38_CR44","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/jnnp.63.2.255a","volume":"63","author":"G Schifitto","year":"1997","unstructured":"Schifitto G, Barbano RL, Kieburtz KD, et al.: HIV related vasculitic mononeuropathy multiplex: a role for IVIg? J Neurol Neurosurg Psychiatry 1997, 63:255\u2013256.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"38_CR45","first-page":"121","volume":"11","author":"TM Gisselbech","year":"1997","unstructured":"Gisselbech TM, Cohen P, Lortharty O, et al.: HIV related vasculitis: clinical presentation and therapeutic approach to six patients. AIDS 1997, 11:121\u2013123.","journal-title":"AIDS"},{"key":"38_CR46","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1201\/b13999-40","volume-title":"Inflammatory Diseases of the Blood Vessels.","author":"D Vassilopoulus","year":"2001","unstructured":"Vassilopoulus D, Calabresse LH: Virus associated vasculitides: clinical. In Inflammatory Diseases of the Blood Vessels. Edited by Hoffman GS, Weyand C. New York: Marcel Dekker; 2001:565\u2013599."}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-005-0038-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-005-0038-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-005-0038-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T17:17:03Z","timestamp":1587575823000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-005-0038-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["38"],"URL":"https:\/\/doi.org\/10.1007\/s11926-005-0038-3","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}